These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 23928292)
1. Mortalin antibody-conjugated quantum dot transfer from human mesenchymal stromal cells to breast cancer cells requires cell-cell interaction. Pietilä M; Lehenkari P; Kuvaja P; Kaakinen M; Kaul SC; Wadhwa R; Uemura T Exp Cell Res; 2013 Nov; 319(18):2770-80. PubMed ID: 23928292 [TBL] [Abstract][Full Text] [Related]
2. CDH1 and IL1-beta expression dictates FAK and MAPKK-dependent cross-talk between cancer cells and human mesenchymal stem cells. Al-toub M; Vishnubalaji R; Hamam R; Kassem M; Aldahmash A; Alajez NM Stem Cell Res Ther; 2015 Jul; 6(1):135. PubMed ID: 26204886 [TBL] [Abstract][Full Text] [Related]
3. Stable and nondisruptive in vitro/in vivo labeling of mesenchymal stem cells by internalizing quantum dots. Ohyabu Y; Kaul Z; Yoshioka T; Inoue K; Sakai S; Mishima H; Uemura T; Kaul SC; Wadhwa R Hum Gene Ther; 2009 Mar; 20(3):217-24. PubMed ID: 19257853 [TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells and carcinoma-associated fibroblasts sensitize breast cancer cells in 3D cultures to kinase inhibitors. Dittmer A; Fuchs A; Oerlecke I; Leyh B; Kaiser S; Martens JW; Lützkendorf J; Müller L; Dittmer J Int J Oncol; 2011 Sep; 39(3):689-96. PubMed ID: 21667024 [TBL] [Abstract][Full Text] [Related]
5. The effect of quantum dot size and poly(ethylenimine) coating on the efficiency of gene delivery into human mesenchymal stem cells. Yang HN; Park JS; Jeon SY; Park W; Na K; Park KH Biomaterials; 2014 Sep; 35(29):8439-49. PubMed ID: 24985737 [TBL] [Abstract][Full Text] [Related]
6. Quantum dot-based mortalin staining as a visual assay for detection of induced senescence in cancer cells. Kaul Z; Yaguchi T; Chiura HX; Kaul SC; Wadhwa R Ann N Y Acad Sci; 2007 Apr; 1100():368-72. PubMed ID: 17460200 [TBL] [Abstract][Full Text] [Related]
7. Exogenous CXCL12 activates protein kinase C to phosphorylate connexin 43 for gap junctional intercellular communication among confluent breast cancer cells. Park JM; Munoz JL; Won BW; Bliss SA; Greco SJ; Patel SA; Kandouz M; Rameshwar P Cancer Lett; 2013 Apr; 331(1):84-91. PubMed ID: 23262036 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer cells and bone marrow mesenchymal stromal cells: a regulated modulation of the breast tumor in the context of immune response. Najar M; Fayyad-Kazan H; Faour WH; Badran B; Journe F; Lagneaux L Inflamm Res; 2017 Feb; 66(2):129-139. PubMed ID: 27783097 [TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-kappaB is central to the expression of truncated neurokinin-1 receptor in breast cancer: implication for breast cancer cell quiescence within bone marrow stroma. Ramkissoon SH; Patel PS; Taborga M; Rameshwar P Cancer Res; 2007 Feb; 67(4):1653-9. PubMed ID: 17308106 [TBL] [Abstract][Full Text] [Related]
10. Effect of truncated neurokinin-1 receptor expression changes on the interaction between human breast cancer and bone marrow-derived mesenchymal stem cells. Zhou Y; Zuo D; Wang M; Zhang Y; Yu M; Yang J; Yao Z Genes Cells; 2014 Sep; 19(9):676-91. PubMed ID: 25130457 [TBL] [Abstract][Full Text] [Related]
11. Mortalin imaging in normal and cancer cells with quantum dot immuno-conjugates. Kaul Z; Yaguchi T; Kaul SC; Hirano T; Wadhwa R; Taira K Cell Res; 2003 Dec; 13(6):503-7. PubMed ID: 14728808 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells. Oh HS; Moharita A; Potian JG; Whitehead IP; Livingston JC; Castro TA; Patel PS; Rameshwar P Cancer Res; 2004 Sep; 64(17):6327-36. PubMed ID: 15342422 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo. Mandel K; Yang Y; Schambach A; Glage S; Otte A; Hass R Stem Cells Dev; 2013 Dec; 22(23):3114-27. PubMed ID: 23895436 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. De Luca A; Lamura L; Gallo M; Maffia V; Normanno N J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871 [TBL] [Abstract][Full Text] [Related]
16. A novel magneto-fluorescent nano-bioprobe for cancer cell targeting, imaging and collection. Wu Y; Chu M; Shi B; Li Z Appl Biochem Biotechnol; 2011 Apr; 163(7):813-25. PubMed ID: 20953733 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells from female donors enhance breast cancer cell proliferation in vitro. Pasanen I; Pietilä M; Lehtonen S; Lehtilahti E; Hakkarainen T; Blanco Sequeiros R; Lehenkari P; Kuvaja P Oncology; 2015; 88(4):214-25. PubMed ID: 25502907 [TBL] [Abstract][Full Text] [Related]
18. Labeling of mesenchymal stem cells with bioconjugated quantum dots. Shah BS; Mao JJ Methods Mol Biol; 2011; 680():61-75. PubMed ID: 21153373 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell-tumor cell cooperation in breast cancer vasculogenesis. Comşa S; Ciuculescu F; Raica M Mol Med Rep; 2012 May; 5(5):1175-80. PubMed ID: 22367291 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the transfer of circulating microRNA between cells mediated by gap junction. Greco SJ; Rameshwar P Methods Mol Biol; 2013; 1024():87-96. PubMed ID: 23719944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]